{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:03:00Z","timestamp":1780340580399,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.10.156","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T01:36:04Z","timestamp":1509932164000},"page":"802-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Hyperinsulinemia-induced PAX6 expression promotes endometrial epithelial cell proliferation via negatively modulating p27 signaling"],"prefix":"10.1016","volume":"97","author":[{"given":"Xue-rong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2009.06.033","article-title":"Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome","volume":"115","author":"Villavicencio","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0010","doi-asserted-by":"crossref","first-page":"e43695","DOI":"10.5812\/ijem.43695","article-title":"Evidence-based and patient-oriented inositol treatment in polycystic ovary syndrome: changing the perspective of the disease","volume":"15","author":"Lagana","year":"2017","journal-title":"Int. J. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2017.10.156_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.06.013","article-title":"Fasting as possible complementary approach for polycystic ovary syndrome: hope or hype?","volume":"105","author":"Chiofalo","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.biopha.2017.10.156_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13304-015-0340-1","article-title":"Surgical treatment of high stage endometrial cancer: current perspectives","volume":"68","author":"Vitale","year":"2016","journal-title":"Updates Surg."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13304-017-0418-z","article-title":"Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up","volume":"69","author":"Cignini","year":"2017","journal-title":"Updates Surg."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13304-017-0419-y","article-title":"Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives","volume":"69","author":"Vitale","year":"2017","journal-title":"Updates Surg."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.156_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/modpathol.2012.174","article-title":"ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas","volume":"26","author":"Werner","year":"2013","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.156_bib0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00011-016-0960-z","article-title":"Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia","volume":"65","author":"Kubyshkin","year":"2016","journal-title":"Inflamm. Res."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.156_bib0045","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/en.2013-1757","article-title":"Inhibitors of SCF-Skp2\/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer","volume":"154","author":"Pavlides","year":"2013","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.biopha.2017.10.156_bib0050","doi-asserted-by":"crossref","first-page":"e48299","DOI":"10.1371\/journal.pone.0048299","article-title":"Transforming growth factor alpha (TGFalpha) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.156_bib0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2016.11.124","article-title":"TET1-GPER-PI3K\/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation","volume":"482","author":"Xie","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1172\/JCI88015","article-title":"PAX6 maintains beta cell identity by repressing genes of alternative islet cell types","volume":"127","author":"Swisa","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.biopha.2017.10.156_bib0065","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1074\/jbc.M117.784629","article-title":"The transcription factor Pax6 is required for pancreatic beta cell identity, glucose-regulated ATP synthesis, and Ca2+ dynamics in adult mice","volume":"292","author":"Mitchell","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.10.156_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.07.008","article-title":"The role of androst-5-ene-3beta,17beta-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome","volume":"89","author":"Plaza-Parrochia","year":"2014","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.biopha.2017.10.156_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1385\/ENDO:29:3:391","article-title":"Distinct regulation of IRS proteins in adipose tissue from obese aged and dexamethasone-treated rats","volume":"29","author":"Caperuto","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.biopha.2017.10.156_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.taap.2016.10.019","article-title":"Dual effect of insulin resistance and cadmium on human granulosa cells \u2212 In vitro study","volume":"313","author":"Belani","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.156_bib0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/cdd.2015.139","article-title":"Unexpected requirement for a binding partner of the syntaxin family in phagocytosis by murine testicular Sertoli cells","volume":"23","author":"Dong","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2017.10.156_bib0090","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1038\/cddis.2014.223","article-title":"Upregulation and nuclear translocation of testicular ghrelin protects differentiating spermatogonia from ionizing radiation injury","volume":"5","author":"Li","year":"2014","journal-title":"Cell. Death. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.156_bib0095","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbagrm.2014.08.006","article-title":"A chromatin modifier regulates Sertoli cell response to mono-(2-ethylhexyl) phthalate (MEHP) via tissue inhibitor of metalloproteinase 2 (TIMP2) signaling","volume":"1839","author":"Zhang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"16","key":"10.1016\/j.biopha.2017.10.156_bib0100","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.febslet.2013.06.029","article-title":"Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells","volume":"587","author":"Yu","year":"2013","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.156_bib0105","doi-asserted-by":"crossref","first-page":"e20894","DOI":"10.1371\/journal.pone.0020894","article-title":"Pax6 expression is sufficient to induce a neurogenic fate in glial progenitors of the neonatal subventricular zone","volume":"6","author":"Jang","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2017.10.156_bib0110","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1210\/en.2016-1213","article-title":"Regulated and functional expression of the corepressor MTA3 in rodent testis","volume":"157","author":"He","year":"2016","journal-title":"Endocrinology"},{"issue":"21","key":"10.1016\/j.biopha.2017.10.156_bib0115","doi-asserted-by":"crossref","first-page":"E1334","DOI":"10.1073\/pnas.1118515109","article-title":"KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing","volume":"109","author":"Ray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.156_bib0120","first-page":"200","article-title":"Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6\/STAT-3\/c-Myc pathway","volume":"6","author":"Subramaniam","year":"2016","journal-title":"Am. J. Cancer. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.156_bib0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1095\/biolreprod.105.041855","article-title":"Null mutation of Kruppel-like factor9\/basic transcription element binding protein-1 alters peri-implantation uterine development in mice","volume":"73","author":"Velarde","year":"2005","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.156_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/JOE-08-0383","article-title":"Nuclear receptor co-regulator Kruppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus","volume":"200","author":"Pabona","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2017.10.156_bib0135","doi-asserted-by":"crossref","first-page":"6517313","DOI":"10.1155\/2016\/6517313","article-title":"Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions","volume":"2016","author":"Vitale","year":"2016","journal-title":"PPAR Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.156_bib0140","first-page":"197","article-title":"Expression levels of PPARgamma and CYP-19 in polycystic ovarian syndrome primary granulosa cells: influence of omega-3 fatty acid","volume":"9","author":"Zaree","year":"2015","journal-title":"Int. J. Fertil. Steril."},{"key":"10.1016\/j.biopha.2017.10.156_bib0145","doi-asserted-by":"crossref","first-page":"471524","DOI":"10.1155\/2012\/471524","article-title":"Altered peroxisome-proliferator activated receptors expression in human endometrial cancer","volume":"2012","author":"Knapp","year":"2012","journal-title":"PPAR Res."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.156_bib0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070999","article-title":"Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives","volume":"17","author":"Lagana","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.156_bib0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2184.2011.00755.x","article-title":"Insulin-like growth factor 2 enhances insulinogenic differentiation of human eyelid adipose stem cells via the insulin receptor","volume":"44","author":"Kang","year":"2011","journal-title":"Cell Prolif."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217344384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217344384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:11:49Z","timestamp":1780337509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217344384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":31,"alternative-id":["S0753332217344384"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.156","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperinsulinemia-induced PAX6 expression promotes endometrial epithelial cell proliferation via negatively modulating p27 signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}